<List><item><source>MED</source><extId>24618851</extId><pmcid>PMC4027981</pmcid><annotations><annotation><prefix>III clinical trial (</prefix><exact>NCT01254019</exact><postfix>) of Drisapersen, an</postfix><tags><tag><name>NCT01254019</name><uri>http://identifiers.org/clinicaltrials/NCT01254019</uri></tag></tags><id>http://europepmc.org/articles/PMC4027981#europepmc-b1587fce83b68e90aa8f678becacc4b8</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>en phase III trial (</prefix><exact>NCT01826487</exact><postfix>) might be able to d</postfix><tags><tag><name>NCT01826487</name><uri>http://identifiers.org/clinicaltrials/NCT01826487</uri></tag></tags><id>http://europepmc.org/articles/PMC4027981#europepmc-e47550fdb0710766a8a79b13a9c81f4b</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation></annotations></item></List>